NORTHERN TRUST CORP - DESIGN THERAPEUTICS INC ownership

DESIGN THERAPEUTICS INC's ticker is DSGN and the CUSIP is 25056L103. A total of 86 filers reported holding DESIGN THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.13 and the average weighting 0.4%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of DESIGN THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$762,891
-62.7%
323,259
-0.5%
0.00%
Q2 2023$2,045,849
+28.6%
324,738
+17.8%
0.00%
Q1 2023$1,591,182
-44.4%
275,768
-1.2%
0.00%
-100.0%
Q4 2022$2,863,874
-39.6%
279,130
-1.6%
0.00%0.0%
Q3 2022$4,744,000
+31.3%
283,695
+9.9%
0.00%0.0%
Q2 2022$3,612,000
+6.0%
258,022
+22.3%
0.00%0.0%
Q1 2022$3,408,000
-24.9%
211,034
-0.5%
0.00%0.0%
Q4 2021$4,540,000
+151.7%
212,015
+72.6%
0.00%
Q3 2021$1,804,000
-33.1%
122,832
-9.4%
0.00%
Q2 2021$2,696,000135,5270.00%
Other shareholders
DESIGN THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
SR ONE CAPITAL MANAGEMENT, LP 5,626,476$78,771,00038.55%
Logos Global Management LP 2,797,501$39,165,0007.18%
Cormorant Asset Management, LP 5,500,000$77,000,0005.82%
Ghost Tree Capital, LLC 275,000$3,850,0002.00%
EcoR1 Capital, LLC 2,634,178$36,878,0001.27%
RA Capital Management 2,186,636$30,613,0000.82%
Vivo Capital, LLC 476,589$6,672,0000.67%
Avoro Capital Advisors LLC 2,222,222$31,111,0000.62%
Artal Group S.A. 400,000$5,600,0000.30%
Rock Springs Capital Management LP 460,391$6,445,0000.19%
View complete list of DESIGN THERAPEUTICS INC shareholders